Zim Laboratories Limited (ZIMLAB) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Zim Laboratories Limited (ZIMLAB) has a cash flow conversion efficiency ratio of 0.036x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs81.71 Million ≈ $883.66K USD) by net assets (Rs2.26 Billion ≈ $24.44 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Zim Laboratories Limited balance sheet independence to measure how much of total assets are equity-financed.
Zim Laboratories Limited - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how Zim Laboratories Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Zim Laboratories Limited to evaluate the quality of earnings relative to operating cash generation.
Zim Laboratories Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zim Laboratories Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
EISO Enterprise Co Ltd
TWO:5291
|
0.010x |
|
Pancontinental Energy NL
AU:PCL
|
-0.064x |
|
Mesa Air Group Inc
NASDAQ:MESA
|
0.054x |
|
Mastermyne Group Ltd
AU:MYE
|
0.071x |
|
Campina Ice Cream Industry Tbk PT
JK:CAMP
|
0.086x |
|
Shinwon
KO:009270
|
0.067x |
|
Chemfab Alkalis Limited
NSE:CHEMFAB
|
0.030x |
|
AmFIRST Real Estate Investment Trust
KLSE:5120
|
0.013x |
Annual Cash Flow Conversion Efficiency for Zim Laboratories Limited (2013–2025)
The table below shows the annual cash flow conversion efficiency of Zim Laboratories Limited from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see ZIMLAB market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs2.52 Billion ≈ $27.28 Million |
Rs411.55 Million ≈ $4.45 Million |
0.163x | +139.30% |
| 2024-03-31 | Rs2.39 Billion ≈ $25.82 Million |
Rs162.78 Million ≈ $1.76 Million |
0.068x | -63.59% |
| 2023-03-31 | Rs2.00 Billion ≈ $21.67 Million |
Rs375.19 Million ≈ $4.06 Million |
0.187x | -33.13% |
| 2022-03-31 | Rs1.76 Billion ≈ $19.00 Million |
Rs492.06 Million ≈ $5.32 Million |
0.280x | +41.33% |
| 2021-03-31 | Rs1.61 Billion ≈ $17.38 Million |
Rs318.51 Million ≈ $3.44 Million |
0.198x | +39.07% |
| 2020-03-31 | Rs1.54 Billion ≈ $16.64 Million |
Rs219.15 Million ≈ $2.37 Million |
0.142x | -38.25% |
| 2019-03-31 | Rs1.51 Billion ≈ $16.34 Million |
Rs348.65 Million ≈ $3.77 Million |
0.231x | -13.92% |
| 2018-03-31 | Rs1.37 Billion ≈ $14.77 Million |
Rs366.13 Million ≈ $3.96 Million |
0.268x | -1.11% |
| 2017-03-31 | Rs1.18 Billion ≈ $12.80 Million |
Rs320.71 Million ≈ $3.47 Million |
0.271x | +21.46% |
| 2016-03-31 | Rs983.37 Million ≈ $10.63 Million |
Rs219.43 Million ≈ $2.37 Million |
0.223x | +276.37% |
| 2015-03-31 | Rs942.10 Million ≈ $10.19 Million |
Rs55.85 Million ≈ $604.04K |
0.059x | +105.44% |
| 2014-03-31 | Rs1.16 Billion ≈ $12.55 Million |
Rs33.48 Million ≈ $362.11K |
0.029x | +113.30% |
| 2013-03-31 | Rs1.07 Billion ≈ $11.55 Million |
Rs-231.81 Million ≈ $-2.51 Million |
-0.217x | -- |
About Zim Laboratories Limited
ZIM Laboratories Limited engages in the development, manufacture, and supply of generic pharmaceutical and nutraceutical products in India and internationally. It provides its products in pre- formulation intermediates and finished formulations in the oral solid dosage forms, such as pellets, taste-masked powders, granules, tablets, capsules, dry syrup, and oral thin films. The company offers the… Read more